| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abraxane (nanoparticle albumin-bound paclitaxel) in metastatic breast cancer
|
|
|
2005
|
|
3 |
p. 214-215
2 p.
|
artikel
|
| 2 |
A community oncologist comments
|
Schwartzberg, Lee S.
|
|
2004
|
|
3 |
p. 139-140
2 p.
|
artikel
|
| 3 |
Adrenal hemorrhage associated with antiphospholipid antibody syndrome
|
Mo, Gyi P.
|
|
2005
|
|
3 |
p. 265-269
5 p.
|
artikel
|
| 4 |
Advances in the treatment of multiple myeloma in patients with chromosome 13 abnormalities
|
Danso, Michael A.
|
|
2007
|
|
3 |
p. 137-140
4 p.
|
artikel
|
| 5 |
A molecular medicine resource
|
Philip, Philip A.
|
|
2006
|
|
3 |
p. 136-
1 p.
|
artikel
|
| 6 |
Anticipating family issues associated with cancer risk assessment and genetic testing
|
Haidle, Joy Larsen
|
|
2005
|
|
3 |
p. 245-250
6 p.
|
artikel
|
| 7 |
Archimedes: oncology's next top model?
|
Bosserman, Linda D.
|
|
2008
|
|
3 |
p. 127-128
2 p.
|
artikel
|
| 8 |
Assessing for physiologic not chronologic age in the elderly
|
Henry, David H.
|
|
2012
|
|
3 |
p. 75-
1 p.
|
artikel
|
| 9 |
Association of spontaneous bilateral femoral stress fractures with zoledronic acid use in a patient with metastatic breast cancer—a cautionary tale
|
Loke, Chandravathi
|
|
2011
|
|
3 |
p. 137-140
4 p.
|
artikel
|
| 10 |
At the corner of Pain and Palliative Care
|
Schwartzberg, Lee S.
|
|
2010
|
|
3 |
p. 103-
1 p.
|
artikel
|
| 11 |
A view from the pharmacy world
|
Rubinstein, Elan
|
|
2008
|
|
3 |
p. 159-
1 p.
|
artikel
|
| 12 |
A welcome addition to the therapeutic armamentarium against colorectal cancer
|
Rakkar, Amol N.
|
|
2007
|
|
3 |
p. 123-125
3 p.
|
artikel
|
| 13 |
Balance of efficacy and toxicity varies with trastuzumab for early breast cancer
|
Slamon, D
|
|
2007
|
|
3 |
p. 165-
1 p.
|
artikel
|
| 14 |
Bench-to-bedside translation of targeted therapies in multiple myeloma
|
Anderson, Kenneth C.
|
|
2012
|
|
3 |
p. 87-93
7 p.
|
artikel
|
| 15 |
Bendamustine: a potential new option for patients with refractory hematologic malignancies
|
Min, Frederick D.
|
|
2008
|
|
3 |
p. 134-135
2 p.
|
artikel
|
| 16 |
Bendamustine in chronic lymphocytic leukemia
|
Abraham, Jame
|
|
2008
|
|
3 |
p. 133-134
2 p.
|
artikel
|
| 17 |
Breast cancer preventive effect of tamoxifen persists after discontinuation of therapy
|
Cuzick, J
|
|
2007
|
|
3 |
p. 164-
1 p.
|
artikel
|
| 18 |
Breast-conservation surgery and adjuvant multicatheter balloon brachytherapy after augmentation mammoplasty
|
Dragun, Anthony E.
|
|
2011
|
|
3 |
p. 134-136
3 p.
|
artikel
|
| 19 |
Cancer genetic counseling: trends in patient referrals and genetic testing in a community-based program
|
Fowler, Eric S.
|
|
2005
|
|
3 |
p. 253-260
8 p.
|
artikel
|
| 20 |
Cancer treatment: it's getting personal
|
Schwartzberg, Lee S.
|
|
2009
|
|
3 |
p. 99-
1 p.
|
artikel
|
| 21 |
Chemotherapy for androgen-independent prostate cancer
|
Tucker, Steven
|
|
2004
|
|
3 |
p. 142-146
5 p.
|
artikel
|
| 22 |
Clinical implications of using nab paclitaxel in metastatic breast cancer
|
Blum, Joanne L.
|
|
2005
|
|
3 |
p. 215-216
2 p.
|
artikel
|
| 23 |
CML patients respond in an early study of kinase inhibitor BMS-354825
|
|
|
2005
|
|
3 |
p. 280-
1 p.
|
artikel
|
| 24 |
CMS releases Medicare drug reimbursement estimates for 2005
|
Okon, Ted
|
|
2004
|
|
3 |
p. 191-192
2 p.
|
artikel
|
| 25 |
Coming together
|
Bowser, Andrew
|
|
2005
|
|
3 |
p. 235-238
4 p.
|
artikel
|
| 26 |
Community oncologists meet in Capital for second annual conference
|
|
|
2007
|
|
3 |
p. 119-
1 p.
|
artikel
|
| 27 |
Community physicians encouraged to consider high-priority phase III trials
|
|
|
2004
|
|
3 |
p. 185-186
2 p.
|
artikel
|
| 28 |
Costly drugs and unfilled scripts: the socioeconomic impact is as devastating as the clinical
|
Schwartzberg, Lee S.
|
|
2011
|
|
3 |
p. 109-110
2 p.
|
artikel
|
| 29 |
Creating partnerships for survival
|
Sborov, Mark
|
|
2012
|
|
3 |
p. 108-109
2 p.
|
artikel
|
| 30 |
Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action
|
Irizarry, Lauren D.
|
|
2009
|
|
3 |
p. 132-134
3 p.
|
artikel
|
| 31 |
Customizing EMR clickables
|
Bosserman, Linda D.
|
|
2008
|
|
3 |
p. 136-138
3 p.
|
artikel
|
| 32 |
Decitabine-induced acute lung injury
|
Marwaha, Monica
|
|
2012
|
|
3 |
p. 106-107
2 p.
|
artikel
|
| 33 |
Descriptive statistics and the normal curve
|
Norman, Geoffrey R.
|
|
2010
|
|
3 |
p. 141-144
4 p.
|
artikel
|
| 34 |
Discover the genius within your organization: the benefits of personality assessment tools
|
Carey, Tina
|
|
2004
|
|
3 |
p. 166-169
4 p.
|
artikel
|
| 35 |
Don't shortchange older cancer patients
|
Lichtman, Stuart M.
|
|
2012
|
|
3 |
p. 81-82
2 p.
|
artikel
|
| 36 |
End of treatment: laugh or cry?
|
Carter, Susan E.
|
|
2004
|
|
3 |
p. 179-181
3 p.
|
artikel
|
| 37 |
EPEC-O: training oncologists in palliative care
|
|
|
2004
|
|
3 |
p. 183-184
2 p.
|
artikel
|
| 38 |
Epoetin alfa for chemotherapy-induced anemia: assessment of two equivalent dosing regimens
|
Policarpo, Gina D.
|
|
2007
|
|
3 |
p. 129-135
7 p.
|
artikel
|
| 39 |
Erlotinib in non-small cell lung cancer
|
|
|
2005
|
|
3 |
p. 205-206
2 p.
|
artikel
|
| 40 |
Evaluation and management of gestational trophoblastic disease
|
Leiser, Aliza L.
|
|
2006
|
|
3 |
p. 152-156
5 p.
|
artikel
|
| 41 |
Extending our reach
|
Schwartzberg, Lee S.
|
|
2005
|
|
3 |
p. 197-198
2 p.
|
artikel
|
| 42 |
Extramedullary BCR-ABL positive T-lymphoblastic leukemia in a patient with chronic myelogenous leukemia
|
Go, Mylene
|
|
2012
|
|
3 |
p. 102-105
4 p.
|
artikel
|
| 43 |
Facing the big-picture problem in healthcare
|
Gould, Randi Londer
|
|
2006
|
|
3 |
p. 133-135
3 p.
|
artikel
|
| 44 |
FDA reorganizes cancer review office
|
|
|
2004
|
|
3 |
p. 190-
1 p.
|
artikel
|
| 45 |
First-line treatment of metastatic breast cancer: current strategies and emerging systemic therapies
|
Brufsky, Adam
|
|
2010
|
|
3 |
p. 115-123
9 p.
|
artikel
|
| 46 |
Fluoropyrimidine therapy: a new chapter in an old story
|
Tucker, Steven J.
|
|
2006
|
|
3 |
p. 127-129
3 p.
|
artikel
|
| 47 |
5-Fluorouracil—induced cardiotoxicity: hints for predicting patients at risk
|
Tejwani, Sheela
|
|
2009
|
|
3 |
p. 105-
1 p.
|
artikel
|
| 48 |
5-Fluorouracil—induced cardiotoxicity: hints for predicting patients at risk
|
Cerny, Jan
|
|
2009
|
|
3 |
p. 105-106
2 p.
|
artikel
|
| 49 |
From ivory tower to next-door neighbor
|
Schwartzberg, Lee S.
|
|
2004
|
|
3 |
p. 135-137
3 p.
|
artikel
|
| 50 |
Genetic testing for hereditary melanoma: controversial, standard of care, or somewhere between the two?
|
Fowler, Eric S.
|
|
2006
|
|
3 |
p. 158-161
4 p.
|
artikel
|
| 51 |
Going it alone
|
Bowser, Andrew
|
|
2005
|
|
3 |
p. 240-241
2 p.
|
artikel
|
| 52 |
Health hazard to community practice nurses: the ‘big worry’
|
Vanchieri, Cori
|
|
2005
|
|
3 |
p. 277-279
3 p.
|
artikel
|
| 53 |
Hereditary melanoma and genetic testing
|
Neff, Gretchen
|
|
2010
|
|
3 |
p. 127-130
4 p.
|
artikel
|
| 54 |
How I treat … ASH
|
Askin, David
|
|
2012
|
|
3 |
p. 112-
1 p.
|
artikel
|
| 55 |
Identifying and treating imatinib failure in chronic myelogenous leukemia: a practical review of treatment guidelines and available agents
|
Goldberg, Stuart L.
|
|
2009
|
|
3 |
p. 113-125
13 p.
|
artikel
|
| 56 |
Is your practice ready for an uncertain future? The questions you should be asking your staff
|
Holcombe, Dawn G.
|
|
2006
|
|
3 |
p. 139-140
2 p.
|
artikel
|
| 57 |
JAK2 gene mutation: impact on pathogenesis, classification, and management of myeloproliferative neoplasms
|
Latif, Naeem
|
|
2010
|
|
3 |
p. 109-114
6 p.
|
artikel
|
| 58 |
Lapatinib-paclitaxel combo shows promise in IBC
|
Cristofanilli, M.
|
|
2007
|
|
3 |
p. 166-
1 p.
|
artikel
|
| 59 |
Leaving nothing to chance: the steps one practice took to stay viable in a poor economy
|
Decker, Veronica
|
|
2010
|
|
3 |
p. 124-126
3 p.
|
artikel
|
| 60 |
Managing follicular rash related to chemotherapy and monoclonal antibodies
|
Hetherington, Judy
|
|
2007
|
|
3 |
p. 157-162
6 p.
|
artikel
|
| 61 |
Medicare recovery audit program going national
|
Finkelstein, Joel B.
|
|
2007
|
|
3 |
p. 171-172
2 p.
|
artikel
|
| 62 |
Medicare reform is shutting patients out
|
Okon, Ted
|
|
2006
|
|
3 |
p. 168-
1 p.
|
artikel
|
| 63 |
Medicare reimbursement ratcheting down
|
Okon, Ted
|
|
2005
|
|
3 |
p. 279-280
2 p.
|
artikel
|
| 64 |
Meetings Highlights & Calendar
|
|
|
2004
|
|
3 |
p. 187-
1 p.
|
artikel
|
| 65 |
Molecular tumor classification using a 92-gene assay in the differential diagnosis of squamous cell lung cancer
|
McGee, Robert S.
|
|
2011
|
|
3 |
p. 123-131
9 p.
|
artikel
|
| 66 |
Moving up in the world: screening for lung cancer
|
Streiner, David L.
|
|
2012
|
|
3 |
p. 110-111
2 p.
|
artikel
|
| 67 |
NCI extends clinical trials to community oncologists
|
Vastag, Brian
|
|
2004
|
|
3 |
p. 189-
1 p.
|
artikel
|
| 68 |
New paperless technology and HIPAA: medical policy at the crossroads
|
Goffman, Thomas E.
|
|
2005
|
|
3 |
p. 201-
1 p.
|
artikel
|
| 69 |
NIH leads effort to lower radiation doses in CT scans
|
Hogan, Monica
|
|
2011
|
|
3 |
p. 143-144
2 p.
|
artikel
|
| 70 |
Nursing considerations when administering panitumumab
|
Knudson, Debra
|
|
2007
|
|
3 |
p. 125-126
2 p.
|
artikel
|
| 71 |
One-click prescribing
|
Cavallo, Jo
|
|
2005
|
|
3 |
p. 229-230
2 p.
|
artikel
|
| 72 |
ONPs as lifelines
|
Davidson, Idelle
|
|
2005
|
|
3 |
p. 223-
1 p.
|
artikel
|
| 73 |
On replicating studies, phase II and phase III trials, and other vagaries of clinical research
|
Streiner, David L.
|
|
2011
|
|
3 |
p. 141-142
2 p.
|
artikel
|
| 74 |
On two fronts in cancer care: politics and treatment
|
Schwartzberg, Lee S.
|
|
2007
|
|
3 |
p. 113-
1 p.
|
artikel
|
| 75 |
Opinion leaders on quality in cancer: views from the field
|
Holcombe, Dawn G.
|
|
2008
|
|
3 |
p. 153-158
6 p.
|
artikel
|
| 76 |
Overcoming the barrier of poor health literacy
|
|
|
2004
|
|
3 |
p. 184-
1 p.
|
artikel
|
| 77 |
Panitumumab in metastatic colorectal cancer
|
Abraham, Jame
|
|
2007
|
|
3 |
p. 121-122
2 p.
|
artikel
|
| 78 |
Patients seeking second medical hematology/oncology opinions in the United States: a report of their demographics and disease processes
|
Curtis, Kelly K.
|
|
2007
|
|
3 |
p. 151-154
4 p.
|
artikel
|
| 79 |
Personalized therapy for cancer: has pharmacogenetics delivered?
|
Allen, Jeffrey
|
|
2009
|
|
3 |
p. 126-131
6 p.
|
artikel
|
| 80 |
Picking the right PDA
|
Fried, John J.
|
|
2006
|
|
3 |
p. 148-149
2 p.
|
artikel
|
| 81 |
PQRI: should you take part?
|
Kruczynski, Mary
|
|
2008
|
|
3 |
p. 139-140
2 p.
|
artikel
|
| 82 |
Predicting the outcome of breast cancer treatment by gene profiling
|
|
|
2004
|
|
3 |
p. 138-
1 p.
|
artikel
|
| 83 |
Preoperative evaluation and treatment of rectal cancer
|
Wu, Zheng
|
|
2010
|
|
3 |
p. 131-135
5 p.
|
artikel
|
| 84 |
Promising therapies, prohibitive costs: a qualitative assessment of the effects of the Medicare Part D doughnut hole on access to costly cancer medications
|
Conwell, Leslie Jackson
|
|
2011
|
|
3 |
p. 111-117
7 p.
|
artikel
|
| 85 |
Providing palliative care and transitioning patients to hospice: how oncologists and palliative care specialists can work together
|
Harrington, Sarah E.
|
|
2010
|
|
3 |
p. 136-140
5 p.
|
artikel
|
| 86 |
Quality and oncology: who's on first?
|
Holcombe, Dawn G.
|
|
2008
|
|
3 |
p. 125-126
2 p.
|
artikel
|
| 87 |
Quality measurement in oncology practices
|
Barr, Thomas R.
|
|
2008
|
|
3 |
p. 145-151
7 p.
|
artikel
|
| 88 |
Radiosurgical treatment of brain metastases in a community oncologic practice
|
Ioffe, Vladimir
|
|
2004
|
|
3 |
p. 149-158
10 p.
|
artikel
|
| 89 |
Recent developments in the treatment of non-small cell lung cancer
|
Abraham, Jame
|
|
2010
|
|
3 |
p. 105-107
3 p.
|
artikel
|
| 90 |
Reduced-fat diet lowers risk of relapse in early-stage breast cancer
|
Chlebowski, RT
|
|
2007
|
|
3 |
p. 168-
1 p.
|
artikel
|
| 91 |
Riding the wave
|
Schwartzberg, Lee S.
|
|
2008
|
|
3 |
p. 118-
1 p.
|
artikel
|
| 92 |
Satellite clinics: friend or foe?
|
Lynch, Conor
|
|
2004
|
|
3 |
p. 171-173
3 p.
|
artikel
|
| 93 |
Sizing up the competition
|
Lynch, Conor
|
|
2004
|
|
3 |
p. 174-178
5 p.
|
artikel
|
| 94 |
Staying proactive
|
Schwartzberg, Lee S.
|
|
2006
|
|
3 |
p. 120-
1 p.
|
artikel
|
| 95 |
Strongyloidiasis diagnosed by endoscopic biopsy in a patient with multiple myeloma
|
Maguire, William F.
|
|
2006
|
|
3 |
p. 144-146
3 p.
|
artikel
|
| 96 |
Study supports weekly nab-paclitaxel for MBC
|
Gradishar, W
|
|
2007
|
|
3 |
p. 166-167
2 p.
|
artikel
|
| 97 |
Synchronous pancreatic cancer and mantle cell lymphoma: a case report
|
Genkin, Igor
|
|
2007
|
|
3 |
p. 144-
1 p.
|
artikel
|
| 98 |
Taking political action
|
Helwick, Caroline
|
|
2008
|
|
3 |
p. 130-131
2 p.
|
artikel
|
| 99 |
Targeted therapy with erlotinib prolongs survival in NSCLC
|
Rigas, James R.
|
|
2005
|
|
3 |
p. 207-209
3 p.
|
artikel
|
| 100 |
Thalidomide– and lenalidomide– associated thromboembolism
|
Bennett, Charles L.
|
|
2007
|
|
3 |
p. 147-148
2 p.
|
artikel
|
| 101 |
The benefits and challenges of conducting clinical trials
|
Jameson, Sharon
|
|
2006
|
|
3 |
p. 163-167
5 p.
|
artikel
|
| 102 |
The controversy surrounding adjuvant therapy for resectable NSCLC is over
|
Monga, Manish
|
|
2010
|
|
3 |
p. 107-108
2 p.
|
artikel
|
| 103 |
The economic concerns when new drugs become available
|
Ratzlaff, Lynn
|
|
2007
|
|
3 |
p. 126-
1 p.
|
artikel
|
| 104 |
The evolving role of molecular diagnosis of cancer types and subtypes: stay tuned
|
Greco, F. Anthony
|
|
2011
|
|
3 |
p. 132-133
2 p.
|
artikel
|
| 105 |
Therapeutic optimization of aromatase inhibitor–associated arthralgia: etiology, onset, resolution, and symptom management in early breast cancer
|
Jones, Cheryl
|
|
2012
|
|
3 |
p. 94-101
8 p.
|
artikel
|
| 106 |
The tallest order: fixing the economy and healthcare
|
Helwick, Caroline
|
|
2009
|
|
3 |
p. 135-136
2 p.
|
artikel
|
| 107 |
The X-ACT trial: lessons learned
|
|
|
2006
|
|
3 |
p. 129-131
3 p.
|
artikel
|
| 108 |
Toxicity of intraperitoneal chemotherapy may be related to age in women treated for optimally debulked ovarian cancer
|
Robinson, William
|
|
2005
|
|
3 |
p. 271-275
5 p.
|
artikel
|
| 109 |
Treatment-induced amenorrhea improves prognosis of early, ER/PR-positive breast cancer
|
Gnant, M
|
|
2007
|
|
3 |
p. 167-168
2 p.
|
artikel
|
| 110 |
Two patients with elevated alpha-fetoprotein levels and liver lesions in the absence of hepatocellular carcinoma
|
Hammad, Nazik
|
|
2009
|
|
3 |
p. 108-111
4 p.
|
artikel
|
| 111 |
Using the COA Medicare Bill Analyzer tool
|
Arena, Francis P.
|
|
2004
|
|
3 |
p. 191-
1 p.
|
artikel
|
| 112 |
Utilizing oncology nurse practitioners: a model strategy
|
Young, Traci
|
|
2005
|
|
3 |
p. 218-220
3 p.
|
artikel
|
| 113 |
Vemurafenib in melanoma with the BRAF V600E mutation
|
Abraham, Jame
|
|
2012
|
|
3 |
p. 85-86
2 p.
|
artikel
|
| 114 |
Vemurafenib's companion assay refines use of the targeted therapy
|
Kirkwood, John M.
|
|
2012
|
|
3 |
p. 83-84
2 p.
|
artikel
|
| 115 |
When dollars and cents—not science—dictate treatment
|
Sethi, Sanjay
|
|
2004
|
|
3 |
p. 159-164
6 p.
|
artikel
|
| 116 |
When patients resist seeing a nurse practitioner
|
Young, Traci
|
|
2005
|
|
3 |
p. 224-
1 p.
|
artikel
|
Tijdschrift beschrijving